PharmEnable has been selected to join Applied AI 3.0, an established 5-month programme aimed at accelerating the growth of successful startups in AI. Delivered by the team at Tech Nation, the cohort is comprised of early-stage UK tech companies applying AI in practical areas with demonstrated real-world impact.
Hannah Sore, CEO of PharmEnable said: “We are delighted to have been selected to the Tech Nation Applied AI 3.0 cohort. We look forward to joining a high caliber network of colleagues and are excited to learn from recognised leaders in the field in this tailored programme for AI companies.”
Applied AI is based on peer-to-peer support and the shared experience of later-stage founders, with a special focus on unpacking the Ai-specific scaling journey. Entering its third year, it has built a network of over 60 alumni, all of them high-growth UK tech companies specialising in AI.
